Biolife Solutions (BLFS) Liabilities and Shareholders Equity (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $400.9 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $400.9 million, up 1.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 2.25% YoY), and the FY2025 annual result was $405.9 million, up 1.6% from the prior year.
• Liabilities and Shareholders Equity eased to $400.9 million in Q1 2026 per BLFS's latest filing, from $405.9 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $544.3 million in Q1 2022 and troughed at $375.0 million in Q2 2024.
• A 5-year average of $423.3 million and a median of $405.9 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 126.76% in 2022 and fell as far as 18.77% in 2022.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $450.2 million in 2022, then fell by 8.33% to $412.7 million in 2023, then decreased by 3.2% to $399.5 million in 2024, then rose by 1.6% to $405.9 million in 2025, then declined by 1.23% to $400.9 million in 2026.
• Business Quant data shows BLFS's Liabilities and Shareholders Equity at $400.9 million in Q1 2026, $405.9 million in Q4 2025, and $392.1 million in Q3 2025.